Involvement of the Nrf2/HO-1 signaling pathway in sulfuretin-induced protection against amyloid beta25-35 neurotoxicity

Neuroscience

Volumn 304, Issue , 2015, Pages 14-28

  Kwon, S H ^a   Ma, S X ^a   Hwang, J Y ^a   Lee, S Y ^a   Jang, C G ^a  

^a Sungkyunkwan University   (South Korea)

Author keywords

Alzheimer's disease; Amyloid beta25 35; Heme oxygenase 1; Neurotoxicity; Nuclear factor erythroid 2 related factor 2; Sulfuretin

Indexed keywords

AMYLOID BETA PROTEIN[25-35]; FLAVONOID; HEME OXYGENASE 1; LACTATE DEHYDROGENASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; SULFURETIN; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (25-35); BENZOFURAN DERIVATIVE; HEME OXYGENASE; HMOX1 PROTEIN, HUMAN; HMOX1 PROTEIN, RAT; NEUROPROTECTIVE AGENT; NFE2L2 PROTEIN, HUMAN; NFE2L2 PROTEIN, RAT; PEPTIDE FRAGMENT;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CELL VIABILITY; CONTROLLED STUDY; DRUG MECHANISM; EMBRYO; ENZYME INDUCTION; ENZYME RELEASE; FEMALE; FETUS; HIPPOCAMPAL NEURONAL CULTURE; HUMAN; HUMAN CELL; NERVE CELL CULTURE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL DEATH; CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECTS; GENE SILENCING; HIPPOCAMPUS; METABOLISM; NERVE CELL; PHYSIOLOGY; SPRAGUE DAWLEY RAT; TUMOR CELL LINE;

AMYLOID BETA-PEPTIDES; ANIMALS; BENZOFURANS; CELL DEATH; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FLAVONOIDS; GENE KNOCKDOWN TECHNIQUES; HEME OXYGENASE (DECYCLIZING); HEME OXYGENASE-1; HIPPOCAMPUS; HUMANS; NEURONS; NEUROPROTECTIVE AGENTS; NF-E2-RELATED FACTOR 2; PEPTIDE FRAGMENTS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84938084733     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2015.07.030     Document Type: Article

References (35)

1. Butterfield D.A., Drake J., Pocernich C., Castegna A. Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide. Trends Mol Med 2001, 7:548-554.
2. Chao X.J., Chen Z.W., Liu A.M., He X.X., Wang S.G., Wang Y.T., Liu P.Q., Ramassamy C., Mak S.H., Cui W., Kong A.N., Yu Z.L., Han Y.F., Pi R.B. Effect of tacrine-3-caffeic acid, a novel multifunctional anti-Alzheimer's dimer, against oxidative-stress-induced cell death in HT22 hippocampal neurons: involvement of Nrf2/HO-1 pathway. CNS Neurosci Ther 2014, 20:840-850.
3. Hur J., Pak S.C., Koo B.S., Jeon S. Borneol alleviates oxidative stress via upregulation of Nrf2 and Bcl-2 in SH-SY5Y cells. Pharm Biol 2013, 51:30-35.
4. Hwang Y.P., Jeong H.G. Ginsenoside Rb1 protects against 6-hydroxydopamine-induced oxidative stress by increasing heme oxygenase-1 expression through an estrogen receptor-related PI3K/Akt/Nrf2-dependent pathway in human dopaminergic cells. Toxicol Appl Pharmacol 2010, 242:18-28.
5. Joshi G., Gan K.A., Johnson D.A., Johnson J.A. Increased Alzheimer's disease-like pathology in the APP/ PS1DeltaE9 mouse model lacking Nrf2 through modulation of autophagy. Neurobiol Aging 2015, 36:664-679.
6. Jung M.J., Chung H.Y., Kang S.S., Choi J.H., Bae K.S., Choi J.S. Antioxidant activity from the stem bark of Albizzia julibrissin. Arch Pharm Res 2003, 26:458-462.
7. Karkkainen V., Pomeshchik Y., Savchenko E., Dhungana H., Kurronen A., Lehtonen S., Naumenko N., Tavi P., Levonen A.L., Yamamoto M., Malm T., Magga J., Kanninen K.M., Koistinaho J. Nrf2 regulates neurogenesis and protects neural progenitor cells against Abeta toxicity. Stem Cells 2014, 32:1904-1916.
8. Keum Y.S. Regulation of Nrf2-mediated phase II detoxification and anti-oxidant genes. Biomol Ther (Seoul) 2012, 20:144-151.
9. Kim S., Park S.E., Sapkota K., Kim M.K., Kim S.J. Leaf extract of Rhus verniciflua stokes protects dopaminergic neuronal cells in a rotenone model of Parkinson's disease. J Pharm Pharmacol 2011, 63:1358-1367.
10. Kim S.S., Lim J., Bang Y., Gal J., Lee S.U., Cho Y.C., Yoon G., Kang B.Y., Cheon S.H., Choi H.J. Licochalcone E activates Nrf2/antioxidant response element signaling pathway in both neuronal and microglial cells: therapeutic relevance to neurodegenerative disease. J Nutr Biochem 2012, 23:1314-1323.
11. Kirkinezos I.G., Moraes C.T. Reactive oxygen species and mitochondrial diseases. Semin Cell Dev Biol 2001, 12:449-457.
12. Kwon S.H., Hong S.I., Ma S.X., Lee S.Y., Jang C.G. 3',4',7-Trihydroxyflavone prevents apoptotic cell death in neuronal cells from hydrogen peroxide-induced oxidative stress. Food Chem Toxicol 2015, 80:41-51.
13. Kwon S.H., Lee H.K., Kim J.A., Hong S.I., Kim S.Y., Jo T.H., Park Y.I., Lee C.K., Kim Y.B., Lee S.Y., Jang C.G. Neuroprotective effects of Eucommia ulmoides Oliv. Bark on amyloid beta(25-35)-induced learning and memory impairments in mice. Neurosci Lett 2011, 487:123-127.
14. Kwon S.H., Ma S.X., Joo H.J., Lee S.Y., Jang C.G. Inhibitory effects of Eucommia ulmoides Oliv. bark on scopolamine-induced learning and memory deficits in mice. Biomol Ther (Seoul) 2013, 21:462-469.
15. Kwon S.H., Ma S.X., Lee S.Y., Jang C.G. Sulfuretin inhibits 6-hydroxydopamine-induced neuronal cell death via reactive oxygen species-dependent mechanisms in human neuroblastoma SH-SY5Y cells. Neurochem Int 2014, 74:53-64.
16. Lee C., Park G.H., Kim C.Y., Jang J.H. [6]-Gingerol attenuates beta-amyloid-induced oxidative cell death via fortifying cellular antioxidant defense system. Food Chem Toxicol 2011, 49:1261-1269.
17. Lee C., Park G.H., Lee S.R., Jang J.H. Attenuation of beta-amyloid-induced oxidative cell death by sulforaphane via activation of NF-E2-related factor 2. Oxid Med Cell Longev 2013, 2013:313510.
18. Lee J.W., Choi Y.J., Park J.H., Sim J.Y., Kwon Y.S., Lee H.J., Kim S.S., Chun W. 3,4,5-Trihydroxycinnamic Acid Inhibits Lipopolysaccharide-Induced Inflammatory Response through the Activation of Nrf2 Pathway in BV2 Microglial Cells. Biomol Ther (Seoul) 2013, 21:60-65.
19. Lee K.W., Chung K.S., Seo J.H., Yim S.V., Park H.J., Choi J.H., Lee K.T. Sulfuretin from heartwood of Rhus verniciflua triggers apoptosis through activation of Fas, Caspase-8, and the mitochondrial death pathway in HL-60 human leukemia cells. J Cell Biochem 2012, 113:2835-2844.
20. Lee Y.R., Hwang J.K., Koh H.W., Jang K.Y., Lee J.H., Park J.W., Park B.H. Sulfuretin, a major flavonoid isolated from Rhus verniciflua, ameliorates experimental arthritis in mice. Life Sci 2012, 90:799-807.
21. Maines M.D. Heme oxygenase 1 transgenic mice as a model to study neuroprotection. Methods Enzymol 2002, 353:374-388.
22. Marlatt M.W., Lucassen P.J., Perry G., Smith M.A., Zhu X. Alzheimer's disease: cerebrovascular dysfunction, oxidative stress, and advanced clinical therapies. J Alzheimers Dis 2008, 15:199-210.
23. Martin D., Rojo A.I., Salinas M., Diaz R., Gallardo G., Alam J., De Galarreta C.M., Cuadrado A. Regulation of heme oxygenase-1 expression through the phosphatidylinositol 3-kinase/Akt pathway and the Nrf2 transcription factor in response to the antioxidant phytochemical carnosol. J Biol Chem 2004, 279:8919-8929.
24. Muller W.E., Romero F.J., Perovic S., Pergande G., Pialoglou P. Protection of flupirtine on beta-amyloid-induced apoptosis in neuronal cells in vitro: prevention of amyloid-induced glutathione depletion. J Neurochem 1997, 68:2371-2377.
25. Nakaso K., Nakamura C., Sato H., Imamura K., Takeshima T., Nakashima K. Novel cytoprotective mechanism of anti-parkinsonian drug deprenyl: PI3K and Nrf2-derived induction of antioxidative proteins. Biochem Biophys Res Commun 2006, 339:915-922.
26. Papaiahgari S., Zhang Q., Kleeberger S.R., Cho H.Y., Reddy S.P. Hyperoxia stimulates an Nrf2-ARE transcriptional response via ROS-EGFR-PI3K-Akt/ERK MAP kinase signaling in pulmonary epithelial cells. Antioxid Redox Signal 2006, 8:43-52.
27. Ramsey C.P., Glass C.A., Montgomery M.B., Lindl K.A., Ritson G.P., Chia L.A., Hamilton R.L., Chu C.T., Jordan-Sciutto K.L. Expression of Nrf2 in neurodegenerative diseases. J Neuropathol Exp Neurol 2007, 66:75-85.
28. Satoh T., Okamoto S.I., Cui J., Watanabe Y., Furuta K., Suzuki M., Tohyama K., Lipton S.A. Activation of the Keap1/Nrf2 pathway for neuroprotection by electrophilic [correction of electrophillic] phase II inducers. Proc Natl Acad Sci USA 2006, 103:768-773.
29. Song J.X., Shaw P.C., Sze C.W., Tong Y., Yao X.S., Ng T.B., Zhang Y.B. Chrysotoxine, a novel bibenzyl compound, inhibits 6-hydroxydopamine induced apoptosis in SH-SY5Y cells via mitochondria protection and NF-kappaB modulation. Neurochem Int 2010, 57:676-689.
30. Song M.Y., Jeong G.S., Kwon K.B., Ka S.O., Jang H.Y., Park J.W., Kim Y.C., Park B.H. Sulfuretin protects against cytokine-induced beta-cell damage and prevents streptozotocin-induced diabetes. Exp Mol Med 2010, 42:628-638.
31. Surh Y.J., Kundu J.K., Na H.K. Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals. Planta Med 2008, 74:1526-1539.
32. Tanaka A., Hamada N., Fujita Y., Itoh T., Nozawa Y., Iinuma M., Ito M. A novel kavalactone derivative protects against H2O2-induced PC12 cell death via Nrf2/ARE activation. Bioorg Med Chem 2010, 18:3133-3139.
33. Wang H.Q., Xu Y.X., Zhu C.Q. Upregulation of heme oxygenase-1 by acteoside through ERK and PI3K/Akt pathway confer neuroprotection against beta-amyloid-induced neurotoxicity. Neurotox Res 2012, 21:368-378.
34. Wang X., McCullough K.D., Franke T.F., Holbrook N.J. Epidermal growth factor receptor-dependent Akt activation by oxidative stress enhances cell survival. J Biol Chem 2000, 275:14624-14631.
35. Yamazaki H., Tanji K., Wakabayashi K., Matsuura S., Itoh K. Role of the Keap1/Nrf2 pathway in neurodegenerative diseases. Pathol Int 2015, 65:210-219.